Multisource Surveillance Study of Pregnancy and Infant Outcomes in Ocrelizumab-Exposed Women With Multiple Sclerosis (MELODIC Study)

28/02/2020
02/07/2024
EU PAS number:
EUPAS33879
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Prot BA39732 OCREVUS v1_Redacted

English (904.19 KB - PDF) View document
Updated protocol

BA39732-protocol-v4-0-2023-03-10-Redacted

First published: 22/02/2024
English (1.11 MB - PDF) View document
Study results
Study report
Other information